Home >Current Issue
Volume: 9, Issue: 8, August, 2019
Natural phytochemicals: Potential anti-HCV targets in silico approachAuthor Affiliations
Objective: To identify phytochemicals as NS5B inhibitors against viral NS5B polymerase in silico model. The NS5B polymerase is a hepatitis C virus (HCV) protein involved in the HCV replication. HCV infection can cause progressive liver damage.
Material and Methods: Molecular docking method is used to identify binding efficiency between the NS5B (PDB ID: 3UPI) and the ligands (phytochemicals), i.e., Gallic acid, Catechin, Resveratrol, Apigenin, and Silibinin. Molinspiration tool is also used to determine the druglikeness properties of ligands (Lipinski’s rules of five). The docking results were compared to the reference ligand, Dasabuvir.
Results: The molecular docking study revealed that all phytochemicals were formed complex with the HCV NS5B polymerase via hydrogen bonding interactions. The phytochemicals showed good binding efficacy with the docking score: gallic acid (−5.47 kcal/mol), catechin (−7.31 kcal/mol), resveratrol (−8.14 kcal/mol), apigenin (−8.75 kcal/mol), and silibinin (−10.75 kcal/mol) compared to the reference drug, Dasabuvir (−11.43 kcal/mol).
Conclusion: The docking results suggested that all phytochemicals showed good binding affinity against hepatitis NS5B polymerase which might be due their antiviral properties.
Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Arumugam M, Muthuswamy U, Kuppusamy AK, Thirumalaisamy S, Varadharajan S, Puliyath J. Computational drug discovery of potential aldose reductase inhibitors using in silico studies. Electronic J Biol, 2012; 8:67-72.
Balavignesh V, Srinivasan E, Ramesh Babu NG. and Saravanan N. Molecular docking study on NS5B polymerase of hepatitis c virus by screening of volatile compounds from Acacia concinna and ADMET prediction. Int J of Pharm Life Sci, 2013; 4:2548-58.
Biswal AR, Venkataraghavan R., Vivek P, Ivo RS. Molecular docking of various bioactive compounds from essential oil of Trachyaspermum ammi against the fungal enzyme Candidapepsin-1. J Appl Pharma Sci, 2019; 9:021-32. https://doi.org/10.7324/JAPS.2019.90503
Burns J, Yokota T, Ashihra H, Lean MEJ, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem, 2002; 50:3337-40. https://doi.org/10.1021/jf0112973
Clin CJ. The global surden of Hepatitis C working group. Global Burden of Disease (GBD) for hepatitis C. Pharmacology, 2009; 44:20-9. https://doi.org/10.1177/0091270003258669
Elfiky AA. Novel guanosine derivatives as anti-HCV NS5b polymerase: a QSAR and molecular docking study. Med Chem, 2019; 15:130-7. https://doi.org/10.2174/1573406414666181015152511
Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C who failed interferon therapy: a randomized, placebo-controlled trial. JAMA, 2012; 308:274-82. https://doi.org/10.1001/jama.2012.8265
Govela-Salas M, Rivas-Estilla AM, Rodríguez-Herrera R, Lozano-Sepúlveda SA, Aguilar-Gonzalez CN, Zugasti-Cruz A, Salas- Villalobos TB, Morlett-Chávez JA. Gallic acid decreases hepatitis C virus expression through its antioxidant capacity. Exp Ther Med, 2016; 11:619-24. https://doi.org/10.3892/etm.2015.2923
Haddad Y, Vallerand D, Brault A, Haddad PS. Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid Based Complement Altern Med, 2011; Article ID:647903:1-10. https://doi.org/10.1093/ecam/nep164
Huang B. MetaPocket: a meta approach to improve protein ligand binding site prediction. Omics, 2009; 13:325-30. https://doi.org/10.1089/omi.2009.0045
Huang B, Schroeder M. Using protein binding site prediction to improve protein docking. Gene, 2008; 422:14-21. https://doi.org/10.1016/j.gene.2008.06.014
Jadon A, Bhadauria M, Shukla S. Protective effect of Terminalia belerica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J Ethnopharmacol, 2007; 109:214-8. https://doi.org/10.1016/j.jep.2006.07.033
Jin G, Lee S, Choi M, Son S, Kim GW, Oh JW, Lee C, Lee K. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors. Eur J Med Chem, 2014; 75:413-25. https://doi.org/10.1016/j.ejmech.2014.01.062
Kortemme T, Morozov AV, Baker D. An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. J Mol Biol, 2003; 326:1239-59. https://doi.org/10.1016/S0022-2836(03)00021-4
Kumar DT, Doss CG. Investigating the inhibitory effect of Wortmannin in the hotspot mutation at Codon 1047 of PIK3CA kinase domain: a molecular docking and molecular dynamics approach. Adv Protein Chem Struct Biol, 2016; 102:267-97. https://doi.org/10.1016/bs.apcsb.2015.09.008
Kumar DT, Doss CG. Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach. J Biomol Struct Dyn, 2017; 35:2745-57. https://doi.org/10.1080/07391102.2016.1231082
Kumar S, Pandey A. Chemistry and biological activities of flavonoids: an overview. Sci World J, 2013; Article ID 162750:1-16. https://doi.org/10.1155/2013/162750
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev, 2012; 64:4-17. https://doi.org/10.1016/j.addr.2012.09.019
Mathew S, Faheem M, Archunan G, Ilyas M, Nargis B, Syed J, Ishtiaq Q, Qahtani. In silico studies of medicinal compounds against hepatitis C capsid protein from North India. Bioinform Biol Insights, 2014; 8:159-68. https://doi.org/10.4137/BBI.S15211
Mishra SS, Gaur R, Gajaram S, Kumar N, Sharma CS, Singh HP. Computational analysis of pharmacokinetic, bioactivity and toxicity parameters of some selected oral-hypoglycaemic agents. Chem Res J, 2018; 3:135-40.
Molinspiration Cheminformatics. Molinspiration. Available via http://www.molinspiration.com/cgi-bin/properties, 2016.
Morris, GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J. Comput Chem, 2009; 16:2785-91. https://doi.org/10.1002/jcc.21256
Panche AN, Diwan A D, Chandra SR. Flavonoids: an overview. J Nutr Sci, 2016; 5:e47. https://doi.org/10.1017/jns.2016.41
Polyak SJ, Ferenci P, Pawlotsky JM. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology, 2013; 57:1262-71. https://doi.org/10.1002/hep.26179
Rekshmyd'dharan S, Roy A. Epicatechin nature's extraordinary therapeutic agent: a review. Int J PharmTech Res, 2013; 5:1816-22.
Sangeetha Vani G, Rajarajan S. A study on in-silico analysis of phytochemicals targeting the proteins of hepatitis B and C virus. Int J Curr Microbiol App Sci, 2015; 4:683-91.
Sankar K, Tamizhmani T, Rama Krishna S, Krishna KVVS, Syam Vardhan M. Simultaneous estimation of gallic acid and rutin in marketed polyherbal formulations by HPTLC. Int J Pharmtech Res, 2012; 4:616-22.
Shakya AK. Medicinal plants: future source of new drugs. Int J Herbal Med, 2016; 4:59-64.
Shimamura T, Zhao WH, Hu ZQ. Mechanism of action and potential for use of tea catechin as an antiinfective agent. Antiinfect Agents Med Chem, 2007; 6:57-62. https://doi.org/10.2174/187152107779314124
Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res, 2010; 27:962-78. https://doi.org/10.1007/s11095-010-0089-7
Thayaillany R, Radha P, Prabhu M. Molecular docking studies of indole derivatives containing cyanide group as hepatitis C Ns5b polymerase inhibitor. Pharma Innovation J, 2015; 4:43-8.
Trivella JP, Gutierrez J, Martin P. Dasabuvir: a new direct antiviral agent for the treatment of hepatitis C. Expert Opin Pharmacother, 2015; 16:617-24. https://doi.org/10.1517/14656566.2015.1012493
Usman AA, Sobia I. Medicinal plants against hepatitis C virus. World J Gastroenterol, 2014; 20:2941-7. https://doi.org/10.3748/wjg.v20.i11.2941
Varun G, Lokesh M, Sandeep M, Sajad Shahbazi, Deepak Reddy G. Novel indole derivatives as hepatitis C virus NS5B polymerase inhibitors: pharmacophore modeling and 3D QSAR studies. Bangladesh J Pharmacol, 2014; 9:290-7. https://doi.org/10.3329/bjp.v9i3.18894
Velazquez F, Venkataraman, S. Lesburg CA. Duca JS, Rosenblum SB, Kozlowski JA, Njoroge FG. Synthesis of novel 4,5-dihydrofurano indoles and their evaluation as HCV NS5B polymerase inhibitors. Org Lett, 2011; 14:556-559. https://doi.org/10.1021/ol203177g
WHO. Global hepatitis report, vol. 4, WHO, Geneva, Switzerland, pp 1-83, 2017.
Xiao Q, Zhu W, Feng W, Lee SS, Leung AW, Shen J, Gao L, Xu C. A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy. Front Pharmacol, 2018; 9:1534. https://doi.org/10.3389/fphar.2018.01534
Yusub A, Hassim H, Hamzah H, Noordin MM. Antiviral activity of resveratrol against human and animal viruses. Adv Virol, 2015; Article ID:184241:1-7. https://doi.org/10.1155/2015/184241